UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
38 hedge funds and large institutions have $5.09M invested in Unity Biotechnology in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 39 → 38 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
60% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 10
Holders
38
Holding in Top 10
3
Calls
$109K
Puts
$24K
Top Buyers
| 1 | +$83.9K | |
| 2 | +$42.8K | |
| 3 | +$20.9K | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$10.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$569 |
Top Sellers
| 1 | -$63.9K | |
| 2 | -$24.1K | |
| 3 | -$14.1K | |
| 4 |
Morgan Stanley
New York
|
-$12.5K |
| 5 |
BlackRock
New York
|
-$10.6K |